Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
weakness in lip movement, which may make it feel different when drinking from a straw or pronouncing certain words (this is rare and dose-dependent)
Stay current on emerging research
The best part is our registered nurses will come right to your door, so you can receive your IV therapy without having to leave your home
If you use compounded products, ensure patients are informed that these drugs are not FDA-approved and that safety data may be limited
Todays approval in the frontline consolidation phase, regardless of MRD status, allows us to reach more patients than ever with this transformative, first-in-class Bispecific T-cell Engager (BiTE) therapy, Jay Bradner, executive vice president of research and development and chief scientific officer at Amgen, said in a press release
US$ 26.75
US$ 20.53
US$ 27.93
US$ 25.28
US$ 22.11
